Main content

    Gastroenterology and Interventional Endoscopy Clinical Trials

    Gastroenterology ServicesOpens new window | Interventional Endoscopy ServicesOpens new window

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Gastroparesis / Gastric Motility

    Active Trials

    Gastroparesis / Gastric Motility

    Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis
    Description: This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.
    Investigator: William Snape, MD
    Eligibility: Subjects 18 to 70 years old with a diagnosis of gastroparesis
    Status: Active and open to enrollment
    Contact: Douglas Troyer, RN, 415-600-1369, Email: about Study Vanda VP-VLY-686-2301

    Title: Use of Domperidone for Treatment of Upper Gastrointestinal Disorders
    Description: This study is to provide oral domperidone to patients where, according to the investigator's judgment, a prokinetic effect is needed for the treatment of refractory symptoms from gastroparesis, functional dyspepsia, or gastroesophageal reflux disease.
    Investigator: Lauren Gerson, MD, MSc
    Eligibility: Subjects 18 years of age and older with symptoms of gastrointestinal disorders
    Status: Active and open to enrollment
    Contact: Lauren Gerson, MD, MSc, 415-674-5200, Email: about Study Domperidone

    • updated May 2017

    Back to top